Feb 22, 2019

Nordic NECT – Early Phase Clinical Trial Course

April, 3rd-5th 2019, at Hotel Lilla Roberts, Helsinki, Finland


This is the first Nordic NECT Course for Early Phase Clinical Trials in Oncology. Helsinki University Hospital will be hosting this course, the first of a possible annual event. For your reference a Nordic Course in Clinical Trials Methodology in Oncology has previously been arranged 6 times, lastly in 2014.

Early clinical trials play a crucial role in drug development. They are in an essential interface between experimental laboratory knowledge and clinical application in patients and include administration of an investigational product to humans first time (“first in human” trials). Early clinical trials require tight adherence to protocol requirements and careful monitoring of patient safety. The field is highly competitive and the requirements for the staff not only include patient care but also maintenance of strict timelines, fast site initiation and patient recruitment, top quality data entry, keeping patient safety always as the priority. Overall, they require resources, dedicated staff and coordination skills.


These and many other issues will be discussed during the course. The aim of the course is to increase participant’s knowledge in early clinical trial methodology and also strengthen important collaborations in research and network-building between the Nordic countries. The language in the course will be English.

For more information an application click on more below.

Last day of application is March 5th, 2019.

Category: General
Posted by: nordicnect

The faculty                          

Sirpa Leppä, Katriina Peltola, and Marita Repo, Helsinki University Hospital, Joan Pietraszek, Rigshospitalet, Denmark, Kristin Øwre, Oslo University Hospital, and Kirsten Thorin Hagene, Nordic NECT



All costs including travelling (train or bus, flights and organized airport transportation) and accommodation will be covered.


Target group                       

Personnel involved in early clinical cancer trials. Basic knowledge in GCP (Good Clinical Practice) and experience in clinical trials is required.


Number of attendees       

Number of attendees will be restricted to 30 (7-8 participants from each country). Selection is based on CV and a motivation letter.



Follow this link to apply for the course. Please have your CV and motivation letter ready to be uploaded. Due to short timelines this application is binding.

For more information contact, Sirpa Leppä at, or Kirsten Thorin Hagene at

Last day of application is March 5th, 2019.

Link to program and invitation letter.